VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
SANEGENEBIO's SGB-9768 (C3 siRNA) Receives NMPA IND Approval for New Indications: PNH and aHUS
SANEGENEBIO's SGB-9768 (C3 siRNA) Receives NMPA IND Approval for New Indications: PNH and aHUS
May 19, 2026 12:00 CST Updated 16:04
Share:
SANEGENEBIO
Small Nucleic Acid Drug Developer